Colon Cancer Clinical Trial

Clinical Trial Finder Colon Cancer Trials

Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin

See Locations Near You

Summary

RATIONALE: Learning how often patients experience nausea and vomiting after receiving anti-vomiting medicine and chemotherapy for colorectal cancer may help doctors plan better treatment and improve patients' quality of life.

PURPOSE: This clinical trial is studying delayed nausea and vomiting in patients with colorectal cancer receiving standard anti-vomiting medicine during the first course of chemotherapy.

View Full Description

Full Description

OBJECTIVES:

To assess the prevalence of delayed nausea and vomiting in patients with colorectal cancer receiving standard anti-emetic medications during the first course of an oxaliplatin-based chemotherapy regimen (mFOLFOX6 or FOLFOX7).

OUTLINE: This is a multicenter study.

Patients undergo collection of demographic, diagnostic, and treatment data at baseline. Patients complete the Functional Living Index-Emesis (FLIE) questionnaire at baseline prior to first chemotherapy infusion and at 5-7 days. Patients also fill out daily patient diaries about symptoms of nausea and vomiting, and use of medications to prevent these symptoms over days 1-5.

View Eligibility Criteria

Eligibility Criteria

DISEASE CHARACTERISTICS:

Diagnosis of colorectal cancer

Currently receiving OR scheduled to receive the first course of either of the following chemotherapy regimens:

mFOLFOX6
FOLFOX7
No clinical or imaging evidence of brain metastasis

PATIENT CHARACTERISTICS:

Able to maintain a diary and complete a standardized quality of life questionnaire in English

PRIOR CONCURRENT THERAPY:

See Disease Characteristics
More than 90 days since prior aprepitant

Study is for people with:

Colon Cancer

Estimated Enrollment:

64

Study ID:

NCT00729677

Recruitment Status:

Completed

Sponsor:

Beth Israel Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Beth Israel Medical Center - Philipps Ambulatory Care Center
New York New York, 10003, United States

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

64

Study ID:

NCT00729677

Recruitment Status:

Completed

Sponsor:


Beth Israel Medical Center

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider